# BLOC-ICH: Interleukin-1 Receptor Antagonist in Intracerebral Haemorrhage

> **NCT03737344** · PHASE2 · COMPLETED · sponsor: **Adrian Parry-Jones** · enrollment: 25 (actual)

## Conditions studied

- Intracerebral Haemorrhage

## Interventions

- **DRUG:** IL-1Ra Kineret®
- **OTHER:** IL-1Ra Placebo

## Key facts

- **NCT ID:** NCT03737344
- **Lead sponsor:** Adrian Parry-Jones
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-05-17
- **Primary completion:** 2021-02-19
- **Final completion:** 2021-04-30
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2021-10-05

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03737344

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03737344, "BLOC-ICH: Interleukin-1 Receptor Antagonist in Intracerebral Haemorrhage". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT03737344. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*